CLINICAL AND SUBCLINICAL CHARACTERISTICS OF INTERSTITIAL LUNG DISEASE RELATED TO SOME CONNECTIVE TISSUE DISEASE

Phương Thúy Đào 1,, Thu Phương Phan 1,2
1 Hanoi medical university
2 Bach Mai hospital

Main Article Content

Abstract

Objectives: To describe the clinical and subclinical characteristics of interstitial lung disease related to some connective tissue disease. Research object and method: Retrospective and prospective cross-sectional description of 102 patients diagnosed with interstitial lung disease with connective tissue disease at the Respiratory Center of Bach Mai Hospital from 1/2021 to 8/2022. The mean age was 57.29±11.55 years old, over 55 years old (65.7%), of which female accounted for 69.6%, the female/male ratio was 2.29/1. Shortness of breath (90.2%) and Coughing up phlegm (44.1%) are the most common symptoms. Rale explosion (85.3%) is the most common physical symptom in the lung. The most common non-respiratory physical symptom was Arthralgia (48%). Anemia accounts for 44.1%, mainly isochromic anemia (39.2%), the average hemoglobin concentration is 121.64±19,735 g/l. The average CK value was 323±603.89 U/L, 27 cases increased CK (30.34%). The mean RF value was 36,773±74.99 IU/mL, in 30 cases increased RF (37.04%). The mean CRP hs concentration was 6.352±7,723 mg/dl. The mean ferritin concentration was 1401±1588 ng/ml. Pulmonary arterial pressure had an average value of 40.32±17,358 mmHg higher than normal, mainly a slight increase in pulmonary artery pressure (61.2%). The mean %FVC compared with the theoretical value is 60.71±15,437, which is lower than normal, mainly due to restrictive ventilation disorder (80%). The most common lesions on baseline HRCT were opacities (69.6%) and traction bronchiectasis (52.9%). The most common lesion morphology was OP (21.6%) and NSIP (19.6%) with the characteristics of bilateral distribution, predominance of the peripheral, lower lobes of the lung. The most common connective tissue disease is Polymyositis/Dermatomyositis (39.3%), followed by Scleroderma (20.6%), Qverlapping Syndrome and Mixed Connective Tissue (20.6%), accounting for the proportion lower than that of Systemic Lupus and Rheumatoid Arthritis. Conclusions: CTD-ILD is very diverse in symptoms, lesion morphology on HRCT, course and prognosis. There are many cases where ILD is the first or only manifestation of CTD, diagnosis of CTD-ILD in these cases is still difficult.

Article Details

References

1. Karakatsani A, Papakosta D, Rapti A, et al. Epidemiology of interstitial lung diseases in Greece. Respir Med. 2009;103(8):1122-1129. doi:10.1016/j.rmed.2009.03.001
2. Alhamad EH. Interstitial lung diseases in Saudi Arabia: A single-center study. Ann Thorac Med. 2013;8(1):33-37. doi:10.4103/1817-1737.105717
3. Dhooria S, Agarwal R, Sehgal IS, et al. Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects. PLoS ONE. 2018;13(2):e0191938. doi:10.1371/journal.pone.0191938
4. Gono T, Kawaguchi Y, Hara M, et al. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatol Oxf Engl. 2010;49(7):1354-1360. doi:10.1093/rheumatology/keq073
5. Outcomes of Treatment of Pulmonary Arterial Hypertension in Patients with Intersitial Lung Disease | C42. SEARCHIN’ FOR A CURE: NEW ILD TREATMENTS. Am Thorac Soc Int Conf Meet Abstr Am Thorac Soc Int Conf Meet Abstr. Accessed October 25, 2022. https:// www.atsjournals.org/doi/epdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4404
6. Martinez-Pitre PJ, Sabbula BR, Cascella M. Restrictive Lung Disease. In: StatPearls. StatPearls Publishing; 2022. Accessed October 25, 2022. http:// www.ncbi.nlm.nih.gov/books/NBK560880/
7. Shao T, Shi X, Yang S, et al. Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations. Front Immunol. 2021;12:684699. doi:10.3389/fimmu.2021.684699
8. Li H, Xiong Z, Liu J, Li Y, Zhou B. [Manifestations of the connective tissue associated interstitial lung disease under high resolution computed tomography]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017;42(8):934-939. doi:10.11817/j.issn.1672-7347.2017.08.010